Orr Inbar

Sales & Marketing

In order to discuss the current unsettled landscape, and just how tariffs might affect patients, pharmaphorum spoke with Orr Inbar of QuantHealth.

Digital

Over 90% of experimental therapies that reach human trials fail to make it to market.

News

Contract research organisation Parexel has bought Vitrana and its AI-powered pharmacovigilance platform for an undisclosed sum.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.